- Global Pharma News & Resources

New research in the fight against Alzheimer's and dementia.

New research in the fight against Alzheimer's and dementia. Up to ONE half of all Alzheimer's Disease can be postponed, reduced or even prevented!

PR Newswire

NEW YORK, Jan. 4, 2019

NEW YORK, Jan. 4, 2019 /PRNewswire/ -- On January 7th, 2019 four world-renowned physicians, researchers and advocates will be sharing their cutting-edge research and prevention methods key to reducing, postponing or even preventing Alzheimer's and other dementia during a global webinar open to the public at (January 7, 201910am EASTERN/ 7am PACIFIC).

The goal for the upcoming webinar is to spark a larger discussion and awareness of this epidemic and of methods that can easily be incorporated into preventative healthcare to greatly reduce and perhaps even prevent various dementias including Alzheimer's. Research by the panelists has shown that greater attention to diet, exercise, cognitive training and vascular and metabolic risk management can reduce cognitive decline. 

By the numbers:

  • The number of people living with dementia, including Alzheimer's, is estimated at 50 million, set to almost double by 2030 and more than triple by 2050.
  • The global cost of dementia was estimated in 2018 at US $1 trillion and this is set to double by 2030.
  • In the United States alone, the cost to government which excludes the substantial family care costs, is $279 billion currently and is estimated to grow to $1.1 trillion by 2050.

Bringing these top world leaders in prevention together is Chuck Stetson, head of the Stetson Family Office, creators of  Mr. Stetson is dedicated to the prevention of Alzheimer's and other chronic disease.  "At a recent meeting of key world opinion leaders in Alzheimer's, I asked the panelists why we were not talking about prevention, given that developing therapeutics for Alzheimer's had a 99 percent failure rate. The panelists refused to answer the question. This is not acceptable."     

The webinar panelists include:

Paola Barbarino, CEO of Alzheimer's Disease International (ADI) which is the global leader in providing information, resources and global advocacy for Alzheimer's disease and other types of dementia. They have shown an increased incidence of Alzheimer's and dementia over the past 100 yearsBarbarino says, "Age is the biggest risk factor for dementia, but dementia is not a natural part of aging. In the continued absence of a cure our thoughts turn to risk reduction and care.  At an individual level, we need clarity and advice on the lifestyle changes we can make right now to try and make a difference.  In addition, if through lifestyle choices we could delay the onset of dementia or reduce its risk, the implications for individuals, families and carers and also health care systems would be immense, and it makes a lot of sense to increase the public debate and awareness around these topics."

Professor Miia Kivipelto, who was the lead researcher in the FINGER study, which is considered to be the baseline for demonstrating that lifestyle intervention of nutritional guidance, exercise, cognitive training and management of vascular risk could greatly prevent or postpone cognitive decline.  Her study has recently expanded to the United States, Europe, China and Singapore as The World Wide Fingers (WW-FINGERS) with results expected to be released by the World Health Organization in early 2019. 

Dr. Kenneth H. Cooper, founder of the world-renowned Cooper Clinic, has been involved in health research and fitness for more than 50 years.  "It is much easier, less costly and more effective to maintain good health than it is to regain it once it is lost. Preventing disease is the mission of Cooper Clinic and has been for nearly 50 years. The concept of prevention also applies to Alzheimer's disease. Since many neurological diseases including Alzheimer's have an incubation period of several decades along with the fact billions of research dollars have been spent unsuccessfully in trying to find a cure for Alzheimer's, it is mandatory that we shift our focus and concentrate more on preventing or at least delaying the onset of this disease," says Kenneth H. Cooper, MD, MPH. 

Dr. Howard Fillit, Founding Executive Director and Chief Science Office of the Alzheimer's Drug Discovery Foundation, is actively working on methods of prevention, as well as working with philanthropists Bill Gates and the Dolby and Schwab Families to develop better ways to diagnose patients. Their Diagnostics Accelerator brings together philanthropic capital with a venture mindset to advance new ideas for easier and more accurate diagnosis of Alzheimer's disease and related dementias. 

The healthcare and caretaker costs associated with Alzheimer's and other chronic diseases are enormous, capable of crippling the economies of entire countries.  Government agencies throughout the world need to understand the necessity of taking proactive steps in the prevention of Alzheimer's and similar diseases for both the health of their people and the welfare of their economic well-being.

Stetson says, "This is a critical issue and it's essential that everyone become aware of the steps that they can take to prevent Alzheimer's and Dementia.  It's incredible that this information is not more widely discussed by the media, health professionals and government agencies as the impact for the greater good would be extraordinary."   For additional information please visit

View original content:

SOURCE Stetson Family Office

Editor Details

Last Updated: 04-Jan-2019